{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T08:11:10Z","timestamp":1698826270370},"reference-count":15,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,12,24]],"date-time":"2009-12-24T00:00:00Z","timestamp":1261612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We analyzed a case with the blastoid variant of mantle cell lymphoma (MCL\u2010BV), a rare subtype of B\u2010cell lymphoma, presenting with marked hypercalcemia at diagnosis. Enzyme\u2010linked immunosorbent assay (ELISA) showed elevated serum levels of interleukin\u20106 (IL\u20106), tumor necrosis factor\u2010\u03b1 (TNF\u2010\u03b1), macrophage inflammatory protein\u20101\u03b1 (MIP\u20101\u03b1), and type I collagen telopeptide, but not parathyroid hormone, calcitriol or parathyroid hormone\u2010related peptide at diagnosis, suggesting local osteoclastic hypercalcemia in this case. By reverse transcription polymerase chain reaction (RT\u2010PCR) analysis, we found predominant expression of mRNA for MIP\u20101\u03b1 in addition to those for receptor\u2010activator of nuclear\u2010factor kappa B ligand (RANKL), TNF\u2010\u03b1, and IL\u20106 in lymphoma cells obtained from the patient. Furthermore, recombinant MIP\u20101\u03b1 significantly stimulated <jats:sup>3<\/jats:sup>H\u2010thymidine uptake by isolated MCL cells <jats:italic>in vitro<\/jats:italic>. Treatment with intravenous fluids, bisphosphonate, and methylprednisolone followed by combination chemotherapy promptly corrects the hypercalcemia and successfully induced complete remission, which was accompanied by a decrease of these cytokines in the serum, including MIP\u20101\u03b1. In the present case, MIP\u20101\u03b1, an osteoclast\u2010activating factor produced by mantle lymphoma cells, may contribute to the development of hypercalcemia. It likely acts through RANKL expression in tumor cells and\/or stroma cells, as indicated in multiple myeloma (MM) and adult T\u2010cell leukemia\/lymphoma (ATLL). Furthermore, MIP\u20101\u03b1 is also involved in the development of an aggressive phenotype on MCL by stimulating proliferation of these lymphoma cells. In summary, the present study demonstrated that MIP\u20101\u03b1 is an important factor in the development of both hypercalcemia and an aggressive phenotype in some types of B\u2010cell lymphoma.<\/jats:p>","DOI":"10.1111\/j.1600-0609.2009.01405.x","type":"journal-article","created":{"date-parts":[[2009,12,24]],"date-time":"2009-12-24T06:55:55Z","timestamp":1261637755000},"page":"448-452","source":"Crossref","is-referenced-by-count":7,"title":["Over\u2010expression of CCL3\u200a\u200aMIP\u20101\u03b1 in a blastoid mantle cell lymphoma with hypercalcemia"],"prefix":"10.1111","volume":"84","author":[{"given":"Norimichi","family":"Hattori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Nakamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotsugu","family":"Ariizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiko","family":"Yamochi\u2010Onizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Tomoyasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,13]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a059154"},{"key":"e_1_2_4_3_2","first-page":"229","volume-title":"World Health Organization Classification of Haematopoietic and Lymphoid Tissues","author":"Swerdlow SH","year":"2008"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.6.2067"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403486"},{"key":"e_1_2_4_6_2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V82.5.1383.1383","article-title":"Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin\u2019s disease and non\u2010Hodgkin\u2019s lymphomas","volume":"82","author":"Seymour JF","year":"1993","journal-title":"Blood"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.8.637-a"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-08-2383"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.2.634"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.24.13931"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190310001593139"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2006.04.014"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.2.671"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.7.3540"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032520"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21579"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2009.01405.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.2009.01405.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T15:36:53Z","timestamp":1698766613000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2009.01405.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,13]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1600-0609.2009.01405.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2009.01405.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,13]]}}}